Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
Mallinckrodt
Citi
Deloitte
Daiichi Sankyo
QuintilesIMS
Moodys
Cerilliant
Chubb

Generated: April 25, 2018

DrugPatentWatch Database Preview

FORTICAL Drug Profile

« Back to Dashboard

Which patents cover Fortical, and what generic alternatives are available?

Fortical is a drug marketed by Upsher-smith Labs and is included in one NDA. There are three patents protecting this drug and one Paragraph IV challenge.

This drug has seven patent family members in five countries.

The generic ingredient in FORTICAL is calcitonin salmon recombinant. There are fourteen drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the calcitonin salmon recombinant profile page.
Summary for FORTICAL
Drug patent expirations by year for FORTICAL
Pharmacology for FORTICAL
Ingredient-typeCalcitonin
Drug ClassCalcitonin
Synonyms for FORTICAL
931C851
AC-28735
AKOS015994646
C145H240N44O48S2
calcitonin (salmon synthetic)
CALCITONIN SALMON RECOMBINANT
CS-5767
HS-2006
HY-P0090
MFCD00133859
MolPort-009-194-175
Salmon calcitonin acetate
W-106060

US Patents and Regulatory Information for FORTICAL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Upsher-smith Labs FORTICAL calcitonin salmon recombinant SPRAY, METERED;NASAL 021406-001 Aug 12, 2005 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial Y ➤ Try a Free Trial
Upsher-smith Labs FORTICAL calcitonin salmon recombinant SPRAY, METERED;NASAL 021406-001 Aug 12, 2005 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial Y ➤ Try a Free Trial
Upsher-smith Labs FORTICAL calcitonin salmon recombinant SPRAY, METERED;NASAL 021406-001 Aug 12, 2005 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial Y ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Paragraph IV (Patent) Challenges for FORTICAL
Drugname Dosage Strength RLD Submissiondate
➤ Subscribe Nasal Spray 200 IU/spray ➤ Subscribe 2006-03-29

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
Covington
Farmers Insurance
Colorcon
UBS
US Department of Justice
Healthtrust
Dow
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.